Acumen Pharmaceuticals, Inc.
ABOSNASDAQHealthcare● Active
$2.27
+$0.10(+4.52%)
Market Cap$137386529
P/E Ratio—
52W High$3.6
52W Low$1.05
Acumen Pharmaceuticals, Inc. (ABOS) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABOS · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.12B | $0.17B | $0.24B | $0.18B | $0.19B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.12B | $0.18B | $0.25B | $0.18B | $0.20B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.12B | $0.24B | $0.31B | $0.20B | $0.23B |
| Liabilities | |||||
| Short-Term Debt | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.03B | $0.03B | $0.01B | $0.01B | $0.01B |
| Long-Term Debt | $0.02B | $0.03B | $0.03B | $0.00B | $0.00B |
| Total Liabilities | $0.05B | $0.06B | $0.04B | $0.01B | $0.01B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.45B) | ($0.33B) | ($0.22B) | ($0.17B) | ($0.13B) |
| Total Stockholders Equity | $0.07B | $0.18B | $0.27B | $0.19B | $0.23B |
| Total Liab & Equity(computed) | $0.12B | $0.24B | $0.31B | $0.20B | $0.23B |
| Debt Summary | |||||
| Total Debt | $0.03B | $0.03B | $0.03B | $0.00B | $0.00B |
| Net Debt | ($0.02B) | ($0.01B) | ($0.04B) | ($0.13B) | ($0.12B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Acumen Pharmaceuticals, Inc. data
About Acumen Pharmaceuticals, Inc. (ABOS) Balance Sheet
Acumen Pharmaceuticals, Inc. (ABOS) balance sheet shows total assets of $0.12B with cash of $0.12B. Total liabilities are $0.05B, total debt $0.03B, and stockholders equity $0.07B.
Frequently asked questions
ABOS · 4 questionsAcumen Pharmaceuticals, Inc. has total debt of $0.03B with net debt of ($0.02B).
ABOS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10